新型冠状病毒

Covid-19 shot accelerates vaccine technology

A look inside the groundbreaking mRNA science underpinning the BioNTech-Pfizer treatment

The news that BioNTech and Pfizer’s Covid-19 vaccine was more than 90 per cent effective in clinical trials has sparked new hope that vaccinations will provide a way out of the coronavirus pandemic.

“The good message for mankind is that we now understand that Covid-19 can be prevented by a vaccine,” Ugur Sahin, BioNTech’s chief executive, said after the announcement.

The phase 3 trial still has to be completed and the data submitted to regulators for approval, but the initial results for the shot, which uses groundbreaking mRNA technology, were a significant milestone in the hunt of a vaccine.

您已阅读11%(598字),剩余89%(5096字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×